Remarkably, E2F8 was reported to promote the transcriptional activation of VEGFA via hypoxia-inducible factor 1 while suppressing the transcription of VEGFR1/2 in endothelial cells during embryonic and tumor development [10,34]. The gene discussed is E2F8; the disease is neoplasm.